117 related articles for article (PubMed ID: 21212718)
1. Challenging special interest groups: whistleblowers may help. Help them!
Braillon A
Psychother Psychosom; 2011; 80(2):116-7. PubMed ID: 21212718
[No Abstract] [Full Text] [Related]
2. Lessons from the Mediator scandal.
Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
[No Abstract] [Full Text] [Related]
3. Mediator: who's to blame?
Braillon A
Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
[No Abstract] [Full Text] [Related]
4. European drug regulator is being investigated by fraud agency.
Kmietowicz Z
BMJ; 2011 Nov; 343():d7283. PubMed ID: 22077089
[No Abstract] [Full Text] [Related]
5. Mediator: who's to blame?
Waller P; Evans S
Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
[No Abstract] [Full Text] [Related]
6. Weighing benefits and risks of drug to treat obesity.
Sukkari SR
CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
[No Abstract] [Full Text] [Related]
7. Benfluorex: how many deaths?
Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
[No Abstract] [Full Text] [Related]
8. Mediator scandal rocks French medical community.
Mullard A
Lancet; 2011 Mar; 377(9769):890-2. PubMed ID: 21409784
[No Abstract] [Full Text] [Related]
9. [What were the indications for the Mediator in 1979?].
Nau JY
Rev Med Suisse; 2011 Feb; 7(281):374-5. PubMed ID: 21416722
[No Abstract] [Full Text] [Related]
10. Mediator: who's to blame?
Vincent L; Guardiola B; Tsouderos Y; Canet E
Lancet; 2011 Jun; 377(9782):2003. PubMed ID: 21665033
[No Abstract] [Full Text] [Related]
11. Benfluorex: increasing reports of valve disorders.
Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
[TBL] [Abstract][Full Text] [Related]
12. Adventures in scientific discourse.
Manson JE
Epidemiology; 1997 May; 8(3):324-7. PubMed ID: 9115032
[No Abstract] [Full Text] [Related]
13. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
Ortensio A; Avagnina S; Costantino A
Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
[No Abstract] [Full Text] [Related]
14. Drug to treat obesity: editorial writer responds.
Faich GA
CMAJ; 1997 Apr; 156(7):978. PubMed ID: 9099162
[No Abstract] [Full Text] [Related]
15. European Medicines Agency withdrawal for sibutramine.
Galhardo J; Davis N; Matthai S; Shield JP
Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736
[No Abstract] [Full Text] [Related]
16. Medical professionalism--focusing on the real issues.
Rothman DJ
N Engl J Med; 2000 Apr; 342(17):1284-6. PubMed ID: 10787328
[No Abstract] [Full Text] [Related]
17. Practical virtue ethics: healthcare whistleblowing and portable digital technology.
Bolsin S; Faunce T; Oakley J
J Med Ethics; 2005 Oct; 31(10):612-8. PubMed ID: 16199607
[TBL] [Abstract][Full Text] [Related]
18. With new diet drug, challenge is weighing patient demand and potential benefit.
Jones L
Ann Intern Med; 1996 Aug; 125(4):I58. PubMed ID: 9446497
[No Abstract] [Full Text] [Related]
19. Mediator scandal engulfs French compensation body.
Mullard A
Lancet; 2013 May; 381(9880):1803. PubMed ID: 23717833
[No Abstract] [Full Text] [Related]
20. Conflicts of interest--editorialists respond.
Manson JE; Faich GA
N Engl J Med; 1996 Oct; 335(14):1064-5. PubMed ID: 8801448
[No Abstract] [Full Text] [Related]
[Next] [New Search]
